Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis
Abstract Aims Although soluble interleukin 2 receptor (sIL‐2R) is a potentially useful biomarker in the diagnosis and evaluation of disease severity in patients with sarcoidosis, its prognostic implication in patients with cardiac sarcoidosis (CS) is unclear. We sought to investigate whether sIL‐2R...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021-12-01
|
| Col·lecció: | ESC Heart Failure |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ehf2.13614 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
